The present invention features 5-deazaflavin compounds, pharmaceutical compositions of 5-deazaflavin compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more 5-deazaflavin compounds of the invention.
申请人:THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as
represented by THE SECRETARY, DEPARTMENT OF HEALTH
AND HUMAN SERVICES
公开号:EP1633749A2
公开(公告)日:2006-03-15
US7498336B2
申请人:——
公开号:US7498336B2
公开(公告)日:2009-03-03
[EN] DEAZAFLAVIN COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSES DE DEAZAFLAVINE ET LEURS METHODES D'UTILISATION
申请人:US HEALTH
公开号:WO2004073615A2
公开(公告)日:2004-09-02
The present invention features 5-deazaflavin compounds, pharmaceutical compositions of 5-deazaflavin compounds and methods of treating a patient suffering from cancer, the method comprising administering to a patient one or more 5-deazaflavin compounds of the invention.